Skip to main content
. 2021 Jul 24;12(7):557–564. doi: 10.5306/wjco.v12.i7.557

Figure 1.

Figure 1

Timeline of neoadjuvant and perioperative therapies in patients with esophagogastric junction cancer. MAGIC: The British Medical Research Council Adjuvant Gastric Infusional Chemotherapy; CROSS: ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study.